Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion
Clinical trial NCT00190788 · COMPLETED
Trial details
- NCT number
- NCT00190788
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.